Skip to main content
Supplement Research and Comparison WebsiteBest Price Guarantee
Supplement Research and Comparison Website

Bacillus coagulans TL3 Inhibits LPS-Induced Caecum Damage in Rat by Regulating the TLR4/MyD88/NF-κB and Nrf2 Signal Pathways and Modulating Intestinal Microflora

  • 2022-02-07
  • Oxidative Medicine and Cellular Longevity 2022
    • Yan Wang
    • Jianxin Lin
    • Ziyang Cheng
    • Tiancheng Wang
    • Jia Chen
    • M. Long

Abstract

Background: Bacillus coagulans has been widely used in food and feed additives, which can effectively inhibit the growth of harmful bacteria, improve intestinal microecological environment, promote intestinal development, and enhance intestinal function, but its probiotic mechanism is not completely clear.

Aim: The aim of this study is to discuss the effect and mechanism of Bacillus coagulans TL3 on oxidative stress and inflammatory injury of cecum induced by LPS.

Method: The Wistar rats were randomly divided into four groups, each containing 7 animals. Two groups were fed with basic diet (the LPS and control, or CON, groups). The remaining groups were fed with basic diet and either a intragastric administration high or low dose of B. coagulans, forming the HBC and LBC groups, respectively. The rats were fed normally for two weeks. On the 15th day, those in the LPS, HBC, and LBC groups were injected intraperitoneally with LPS-the rats in the CON group were injected intraperitoneally with physiological saline. After 4 hours, all the rats were anesthetized and sacrificed by cervical dislocation, allowing samples to be collected and labeled. The inflammatory and antioxidant cytokine changes of the cecum were measured, and the pathological changes of the cecum were observed, determining the cecal antioxidant, inflammation, and changes in tight junction proteins and analysis of intestinal flora.

Result: The results show that LPS induces oxidative damage in the cecal tissues of rats and the occurrence of inflammation could also be detected in the serum. The Western blot results detected changes in the NF-κ_B- and Nrf2-related signaling pathways and TJ-related protein levels. Compared with the LPS group, the HBC group showed significantly downregulated levels of expression of Nrf2, NQO1, HO-1, GPX, and GCLC. The expression of TLR4, MYD88, NF-κ_B, IL-6, TNF_α, and IL-1_β was also significantly downregulated, while the expression of other proteins (ZO-1, occludin, and claudin-1) increased significantly. Bacillus coagulans TL3 was also found to increase the relative abundance of the beneficial bacterium Akkermansia muciniphila in the intestines. There is also a significant reduction in the number of harmful bacteria Escherichia coli and Shigella (Enterobacteriaceae).

Conclusion: Bacillus coagulans TL3 regulates the TLR4/MyD88/NF-_κ_B and Nrf2 signaling pathways in the cecal tissue of rats, protects the intestine from inflammation and oxidative damage caused by LPS, and inhibits the reproduction of harmful bacteria and promotes beneficial effects by regulating the intestinal flora bacteria grow, thereby enhancing intestinal immunity.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Bacillus coagulansAltered Gut MicrobiotaBeneficial
Moderate
Bacillus coagulansImproved Intestinal Barrier FunctionBeneficial
Large
Bacillus coagulansReduced Inflammation LevelsBeneficial
Large
Bacillus coagulansReduced Oxidative DamageBeneficial
Large
Bacillus coagulans MTCC 5856Improved Beneficial Intestinal BacteriaBeneficial
Large
Bacillus coagulans MTCC 5856Improved Intestinal Barrier FunctionBeneficial
Large
Bacillus coagulans MTCC 5856Reduced Harmful Intestinal BacteriaBeneficial
Large
Bacillus coagulans MTCC 5856Reduced Oxidative Damage in Cecal TissuesBeneficial
Large
Bacillus coagulans ProDuraImproved Gut MicrofloraBeneficial
Moderate
Bacillus coagulans ProDuraImproved Tight Junction Protein ExpressionBeneficial
Moderate
Bacillus coagulans ProDuraReduced Harmful Gut BacteriaBeneficial
Large
Bacillus coagulans ProDuraReduced Inflammatory ResponseBeneficial
Large
Bacillus coagulans ProDuraReduced Oxidative Damage in Cecal TissuesBeneficial
Large
Bacillus coagulans SC208Enhanced Intestinal ImmunityBeneficial
Moderate
Bacillus coagulans SC208Improved Abundance of Beneficial BacteriaBeneficial
Moderate
Bacillus coagulans SC208Improved Intestinal Barrier FunctionBeneficial
Large
Bacillus coagulans SC208Reduced Bacterial LevelsBeneficial
Moderate
Bacillus coagulans SC208Reduced Inflammation LevelsBeneficial
Large
Bacillus coagulans SC208Reduced Oxidative DamageBeneficial
Large
Bacillus coagulans SNZ-1969Enhanced Gut Flora CompositionBeneficial
Moderate
Bacillus coagulans SNZ-1969Improved Intestinal Barrier IntegrityBeneficial
Moderate
Bacillus coagulans SNZ-1969Reduced Harmful Gut MicrobiotaBeneficial
Moderate
Bacillus coagulans SNZ-1969Reduced Intestinal InflammationBeneficial
Large
Bacillus coagulans SNZ-1969Reduced Oxidative Damage in Intestinal TissueBeneficial
Large
Bacillus coagulans Unique IS-2Enhanced Intestinal ImmunityBeneficial
Moderate
Bacillus coagulans Unique IS-2Improved Gut Microbiome CompositionBeneficial
Moderate
Bacillus coagulans Unique IS-2Improved Intestinal Barrier FunctionBeneficial
Large
Bacillus coagulans Unique IS-2Reduced Harmful BacteriaBeneficial
Large
Bacillus coagulans Unique IS-2Reduced Hepatic Oxidative StressBeneficial
Large
Bacillus coagulans Unique IS-2Reduced Inflammation LevelsBeneficial
Large
Back to top